bit.bio specializes in synthetic biology for human health, providing a platform for deterministic cell programming and manufacturing human cell types at scale with precision and consistency.
peer of
investor of
Metrics
marketPRIVATE
msh_idBIO:BIT
localegb
websitehttps://www.bit.bio/
source_ref483ba69a-bab2-46ea-bf7b-65fe8fa6e14a
products_or_servicesTherapeutics, customized cells (ioCells), disease model cells, CRISPR-Ready ioCells, and platform for cell programming.
United Kingdom